Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.
about
Cardiovascular disease in lupus: insights and updatesThe detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosus.An essential role of caspase 1 in the induction of murine lupus and its associated vascular damageActivation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.Aortic Atherosclerosis in Systemic Lupus ErythematosusPeptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells.The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosusInflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.High dietary fat promotes visceral obesity and impaired endothelial function in female mice with systemic lupus erythematosusInterleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitorsEndothelial progenitor cells: a new player in lupus?Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosisCD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production.Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupusDifferential expression of functional Fc-receptors and additional immune complex receptors on mouse kidney cellsA role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity.Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Why are kids with lupus at an increased risk of cardiovascular disease?Understanding mechanisms of hypertension in systemic lupus erythematosus.Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation.Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.Aortic aneurysm association with SLE - a case-control study.How does interferon-α insult the vasculature? Let me count the waysNovel Insights in Systemic Lupus Erythematosus and Atherosclerosis.Accelerated model of lupus autoimmunity and vasculopathy driven by toll-like receptor 7/9 imbalance.
P2860
Q27016554-E998540C-3247-48EF-94CD-7841117DD217Q30497355-6D18FFD8-F4A1-4CB2-AE09-EEC19273A65CQ33588015-90FA279D-FA84-4D83-B0F0-2E39CD12436EQ34055844-4A2E47BB-4BD3-4121-8051-A45BB322A970Q34240254-B68FA162-5D84-401F-B963-AE345EF67936Q34273836-0F06542C-5723-4AAA-8FAB-F2A5CF5210A0Q34290113-CA55DD9F-3619-4EAC-B4A0-40BF8C68455CQ34938841-E49983F7-BDB6-4EDC-AA02-3010B0FE437CQ35060808-C13ED7D4-15A9-4E96-8017-3628819BCFB8Q35145964-3933BF03-EAE0-45D4-8175-FAB0F719AA29Q35169351-AA46CEA1-AD61-4C0C-B013-E417C6292B4DQ35543444-A85A992F-5088-413E-BB13-B34D3F5C738EQ35566819-25FFC640-39DA-4CCD-AB9C-74D72CF55A8FQ35587694-995A2E7A-0D7A-4F80-AA19-38062D9F429CQ35661943-3BF4B4BA-31AA-4E20-877D-071DEF7F3084Q36084953-8E14288B-E9C3-4444-8C6E-FE6802B5E631Q36126483-39326602-D7F5-47F6-998F-2FFDB6F0D48AQ36139902-6D1AC47D-51E2-42DD-8150-C3CF0F8BD09BQ36166909-17B8FEAA-B25F-477E-B0F6-FE5517DF2FE5Q36966870-FFE167C8-5E6A-47E6-AA7A-AD8F5F7412D1Q37237914-BA62CEDE-4606-480D-BFDC-29754A07CAE5Q37624342-235825C4-577F-498B-84C5-ED94152C2100Q37699812-D2F663D8-B27B-47AE-8B8B-F9B6AB0DAFBBQ38335622-E0847459-FFBC-4AFC-92C0-C2093080E023Q38591752-3C7A9413-E35F-4687-8313-7168DC8AF41CQ38777852-EA3B9AD5-B4A0-4D47-AC3B-999AC9625FEBQ39367860-05C17F34-B5E1-40FF-8A6D-CA74E71C6DE0Q39586997-644AE6F0-FE14-40C6-A073-3CA2856B5CF4Q40950663-7E04D003-751D-4C9F-9117-0C232450E4C9Q42703913-19153CBA-F261-4657-BB12-BF30B36A5100Q50052184-1A581335-5DD5-417A-8460-CA37E17575EEQ55402266-550D16BE-EC6B-4027-9814-491D2CF9A096
P2860
Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lupus-prone New Zealand Black/ ...... endothelial progenitor cells.
@ast
Lupus-prone New Zealand Black/ ...... endothelial progenitor cells.
@en
type
label
Lupus-prone New Zealand Black/ ...... endothelial progenitor cells.
@ast
Lupus-prone New Zealand Black/ ...... endothelial progenitor cells.
@en
prefLabel
Lupus-prone New Zealand Black/ ...... endothelial progenitor cells.
@ast
Lupus-prone New Zealand Black/ ...... endothelial progenitor cells.
@en
P2093
P2860
P356
P1433
P1476
Lupus-prone New Zealand Black/ ...... endothelial progenitor cells.
@en
P2093
P2860
P304
P356
10.1177/0961203309353773
P577
2010-01-12T00:00:00Z